Toxic phytochemicals and their potential risks for human cancer

Cancer Prevention Research

Volumn 8, Issue 1, 2015, Pages 1-8

  Bode, Ann M ^a   Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYGDALIN; ARISTOLOCHIC ACID; CAPSAICIN; METHYLAZOXYMETHANOL GLUCOSIDE; PHORBOL ESTER; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT; PTAQUILOSIDE; PYRROLIZIDINE ALKALOID; SAFROLE; INDAN DERIVATIVE; PLANT EXTRACT; SESQUITERPENE;

CANCER RISK; DIET; HERBAL MEDICINE; HUMAN; PRIORITY JOURNAL; REVIEW; CHEMISTRY; DRUG SCREENING; NEOPLASMS; PHYTOTHERAPY; PLANT; TUMOR CELL LINE;

AMYGDALIN; ARISTOLOCHIC ACIDS; CAPSAICIN; CELL LINE, TUMOR; CYCASIN; DIET; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDANS; NEOPLASMS; PHORBOL ESTERS; PHYTOCHEMICALS; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS; PYRROLIZIDINE ALKALOIDS; SAFROLE; SESQUITERPENES;

EID: 84920843939     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0160     Document Type: Review

References (117)

1. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr 2011;141:261-6.
2. Correa-Velez I, Clavarino A, Eastwood H. Surviving, relieving, repairing, and boosting up: reasons for using complementary/alternative medicine among patients with advanced cancer: a thematic analysis. J Palliat Med 2005;8:953-61.
3. Fratamico PM, Wasilenko JL, Garman B, Demarco DR, Varkey S, Jensen M, et al. Evaluation of a multiplex real-time PCR method for detecting shiga toxin-producing Escherichia coli in beef and comparison to the U.S. department of agriculture food safety and inspection service microbiology laboratory guidebook method. J Food Prot 2014;77:180-8.
4. Funk J, Stoeber H, Hauser E, Schmidt H. Correction:molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant. BMC Microbiol 2014;14:32.
5. Gaige S, Djelloul M, Tardivel C, Airault C, Felix B, Jean A, et al. Modification of energy balance induced by the food contaminant T-2 toxin: a multimodal gut-to-brain connection. Brain Behav Immun 2014;37:54-72.
6. Yeung KS, Gubili J, Cassileth B. Evidence-based botanical research: applications and challenges. Hematol Oncol Clin North Am 2008;22:661-70, viii.
7. Shahrokh LE, Lukaszuk JM, Prawitz AD. Elderly herbal supplement users less satisfied with medical care than nonusers. J Am Diet Assoc 2005;105:1138-40.
8. Stanker LH, Scotcher MC, Cheng L, Ching K, McGarvey J, Hodge D, et al. A monoclonal antibody based capture ELISA for botulinum neurotoxin serotype B: toxin detection in food. Toxins 2013;5:2212-26.
9. Funk J, Stoeber H, Hauser E, Schmidt H. Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant. BMC Microbiol 2013;13:230.
10. Lorenz SC, Son I, Maounounen-Laasri A, Lin A, Fischer M, Kase JA. Prevalence of hemolysin genes and comparison of ehxA subtype patterns in Shiga toxin-producing Escherichia coli (STEC) and non-STEC strains from clinical, food, and animal sources. Appl Environ Microbiol 2013;79:6301-11.
11. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The alpha-tocopherol, beta carotene cancer prevention study group. N Engl J Med 1994;330:1029-35.
12. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
13. Omenn GS, Goodman G, Thornquist M, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers. Can Res 1994;54:2038s-43s.
14. Neuhouser ML, Patterson RE, Thornquist MD, Omenn GS, King IB, Goodman GE. Fruits and vegetables are associatedwith lower lung cancer risk only in the placebo arm of the beta-carotene and retinol efficacy trial (CARET). Cancer Epidemiol Biomarkers Prev 2003;12:350-8.
15. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. Jama 2003;290:476-85.
16. Taylor PR, AlbanesD. Selenium, vitamin E, and prostate cancer - ready for prime time? J Natl Cancer Inst 1998;90:1184-5.
17. Brawley OW, Parnes H. Prostate cancer prevention trials in the USA. Eur J Cancer 2000;36:1312-5.
18. Kumar NB, Besterman-Dahan K. Nutrients in the chemoprevention of prostate cancer: current and future prospects. Cancer Control 1999;6:580-6.
19. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
20. Perry L, Dickau R, Zarrillo S, Holst I, Pearsall DM, Piperno DR, et al. Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L.) in the Americas. Science 2007;315:986-8.
21. Bode AM, Dong Z. The two faces of capsaicin. Cancer Res 2011;71:2809-14.
22. Ojo OE, Ajuwape AT, Otesile EB, Owoade AA, Oyekunle MA, Adetosoye AI. Potentially zoonotic shiga toxin-producing Escherichia coli serogroups in the faeces andmeat of food-producing animals in Ibadan, Nigeria. Int J Food Microbiol 2010;142:214-21.
23. Immonen E, Kummu M, Petsalo A, Pihlaja T, Mathiesen L, Nielsen JK, et al. Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic metabolism. Placenta 2010;31:641-8.
24. Serra I, Yamamoto M, Calvo A, Cavada G, Baez S, Endoh K, et al. Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer 2002;102:407-11.
25. Lopez-Carrillo L, Hernandez Avila M, Dubrow R. Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am J Epidemiol 1994;139:263-71.
26. Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6:357-72.
27. Hautkappe M, Roizen MF, Toledano A, Roth S, Jeffries JA, Ostermeier AM. Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J Pain 1998;14:97-106.
28. Bode AM, Cho YY, Zheng D, Zhu F, Ericson ME, Ma WY, et al. Transient receptor potential type vanilloid 1 suppresses skin carcinogenesis. Cancer Res 2009;69:905-13.
29. Hwang MK, Bode AM, Byun S, Song NR, Lee HJ, Lee KW, et al. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1. Cancer Res 2010;70:6859-69.
30. Laqueur GL, Spatz M. Toxicology of cycasin. Cancer Res 1968;28:2262-7.
31. Kisby GE, Fry RC, Lasarev MR, Bammler TK, Beyer RP, Churchwell M, et al. The cycad genotoxinMAMmodulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS ONE 2011;6:e20911.
32. Thorgeirsson UP, Dalgard DW, Reeves J, Adamson RH. Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regul Toxicol Pharmacol 1994;19:130-51.
33. Sieber SM, Correa P, Dalgard DW, McIntire KR, Adamson RH. Carcinogenicity and hepatotoxicity of cycasin and its aglycone methylazoxymethanol acetate in nonhuman primates. J Natl Cancer Inst 1980;65:177-89.
34. Fukunishi R, Kadota A, Yoshida A, Hirota N. Induction of tumors with cycasin in newborn and preweanling rats. J Natl Cancer Inst 1985;74:1275-81.
35. Niemeyer HB, Honig DM, Kulling SE, Metzler M. Studies on the metabolism of the plant lignans secoisolariciresinol and matairesinol. J Agric Food Chem 2003;51:6317-25.
36. Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN, Khaw KT. Breast, colorectal, and prostate cancer risk in the European prospective investigation into cancer and nutrition-norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 2010;91:440-8.
37. Torres-Sanchez L, Galvan-Portillo M, Wolff MS, Lopez-Carrillo L. Dietary consumption of phytochemicals and breast cancer risk in Mexican women. Public Health Nutr 2009;12:825-31.
38. Linseisen J, Piller R, Hermann S, Chang-Claude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2004;110:284-90.
39. TouillaudMS, Thiebaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 2007;99:475-86.
40. van Duursen MB, Nijmeijer SM, deMorree ES, de Jong PC, van den Berg M. Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology 2011;289:67-73.
41. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008;29:2162-8.
42. Li J, Chen J, Vidal JE, McClane BA. The Agr-like quorum-sensing system regulates sporulation and production of enterotoxin and beta2 toxin by Clostridium perfringens type A non-food-borne human gastrointestinal disease strain F5603. Infect Immun 2011;79:2451-9.
43. Alonso-Amelot ME, Avendano M. Possible association between gastric cancer and bracken fern in Venezuela: an epidemiologic study. Int J Cancer 2001;91:252-9.
44. Potter DM, Baird MS. Carcinogenic effects of ptaquiloside in bracken fern and related compounds. Br J Cancer 2000;83:914-20.
45. Seawright AA. Directly toxic effects of plant chemicals which may occur in human and animal foods. Nat Toxins 1995;3:227-32; discussion 42.
46. Shahin M, Moore MR, Worrall S, Smith BL, Seawright AA, Prakash AS. Hras activation is an early event in the ptaquiloside-induced carcinogenesis: comparison of acute and chronic toxicity in rats. Biochem Biophys Res Commun 1998;250:491-7.
47. Shahin M, Smith BL, Worral S, Moore MR, Seawright AA, Prakash AS. Bracken fern carcinogenesis: multiple intravenous doses of activated ptaquiloside induce DNA adducts, monocytosis, increased TNF alpha levels, and mammary gland carcinoma in rats. Biochem Biophys Res Commun 1998;244:192-7.
48. Masuda EK, Kommers GD, Martins TB, Barros CS, Piazer JV. Morphological factors as indicators of malignancy of squamous cell carcinomas in cattle exposed naturally to bracken fern (Pteridium aquilinum). J Comp Pathol 2010;144:48-54.
49. Evans IA, Jones RS, Mainwaring-Burton R. Passage of bracken fern toxicity into milk. Nature 1972;237:107-8.
50. Campos-da-Paz M, Pereira LO, Bicalho LS, Dorea JG, Pocas-Fonseca MJ, Santos MdeF. Interaction of bracken-fern extract with vitaminCin human submandibular gland and oral epithelium cell lines. Mutat Res 2008;652:158-63.
51. Alonso-Amelot ME, Avendano M. Human carcinogenesis and bracken fern: a review of the evidence. Curr Med Chem 2002;9:675-86.
52. Liu TY, Chen CC, Chen CL, Chi CW. Safrole-induced oxidative damage in the liver of Sprague-Dawley rats. Food Chem Toxicol 1999;37:697-702.
53. Liu TY, Chung YT, Wang PF, Chi CW, Hsieh LL. Safrole-DNA adducts in human peripheral blood-an association with areca quid chewing and CYP2E1 polymorphisms. Mutat Res 2004;559:59-66.
54. Lee JM, Liu TY, Wu DC, Tang HC, Leh J, Wu MT, et al. Safrole-DNA adducts in tissues from esophageal cancer patients: clues to areca-related esophageal carcinogenesis. Mutat Res 2005;565:121-8.
55. Chung YT, Chen CL, Wu CC, Chan SA, Chi CW, Liu TY. Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing. Toxicol Lett 2008;183:21-7.
56. Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2003;39:728-35.
57. Benedetti MS, Malnoe A, Broillet AL. Absorption, metabolism and excretion of safrole in the rat and man. Toxicology 1977;7:69-83.
58. Sun QZ, Li ZJ, Li J, Wang YT, Jin D, Zheng X, et al.[Secretion expression of cholera toxin B subunit in food-grading Lactococcus lactis expression system]. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30:1288-91.
59. 2+ increases and death in human osteosarcoma cells. Pharmacol Res 2006;54:103-10.
60. 2+ mobilization and cytotoxicity in human PC3 prostate cancer cells. J Recept Signal Transduct Res 2006;26:199-212.
61. Meneely JP, Sulyok M, Baumgartner S, Krska R, Elliott CT. A rapid optical immunoassay for the screening of T-2 and HT-2 toxin in cereals and maize-based baby food. Talanta 2010;81:630-6.
62. Du A, Zhao B, Yin D, Zhang S, Miao J. Safrole oxide induces apoptosis by activating caspase-3, -8, and -9 in A549 human lung cancer cells. Bioorg Med Chem Lett 2006;16:81-3.
63. Oses SM, Rantsiou K, Cocolin L, Jaime I, Rovira J. Prevalence and quanti fi cation of Shiga-toxin producing Escherichia coli along the lamb food chain by quantitative PCR. Int J Food Microbiol 2010;141:S163-9.
64. Kanki M, Seto K, Sakata J, Harada T, Kumeda Y. Simultaneous enrichment of shiga toxin-producing Escherichia coli O157 and O26 and Salmonella in food samples using universal preenrichment broth. J Food Prot 2009;72:2065-70.
65. 2+]i increases and cell proliferation induced by the carcinogen safrole in human oral cancer cells. Naunyn Schmiedebergs Arch Pharmacol 2005;372:88-94.
66. Jones RG, Marks JD. Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism. J Med Microbiol 2013;62:828-35.
67. Diercke M, Kirchner M, Claussen K, Mayr E, Strotmann I, Frangenberg J, et al. Transmission of shiga toxin-producing Escherichia coli O104:H4 at a family party possibly due to contamination by a food handler, Germany 2011. Epidemiol Infect 2014;142:99-106.
68. Wang F, Yang Q, Kase JA, Meng J, Clotilde LM, Lin A, et al. Current trends in detecting non-O157 Shiga toxin-producing Escherichia coli in food. Foodborne Pathog Dis 2013;10:665-77.
69. Srivastava S, Kumar V, Ali MA, Solanki PR, Srivastava A, Sumana G, et al. Electrophoretically deposited reduced graphene oxide platform for food toxin detection. Nanoscale 2013;5:3043-51.
70. Swain E, Poulton JE. Utilization of amygdalin during seedling development of prunus serotina. Plant Physiol 1994;106:437-45.
71. Lerner IJ. Laetrile: a lesson in cancer quackery. CA Cancer J Clin 1981;31:91-5.
72. Fenselau C, Pallante S, Batzinger RP, Benson WR, Barron RP, Sheinin EB, et al. Mandelonitrile beta-glucuronide: synthesis and characterization. Science 1977;198:625-7.
73. Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. A pharmacologic and toxicological study of amygdalin. JAMA 1981;245:591-4.
74. O'Brien B, Quigg C, Leong T. Severe cyanide toxicity from 'vitamin supplements'. Eur J Emerg Med 2005;12:257-8.
75. Milazzo S, Lejeune S, Ernst E. Laetrile for cancer: a systematic reviewof the clinical evidence. Support Care Cancer 2007;15:583-95.
76. Milazzo S, Ernst E, Lejeune S, Schmidt K. Laetrile treatment for cancer. Cochrane Database Syst Rev 2006:CD005476.
77. Unproven methods of cancer management. Laetrile. CA Cancer J Clin 1991;41:187-92.
78. Nolin TD, Himmelfarb J. Mechanisms of drug-induced nephrotoxicity. Handb Exp Pharmacol 2010:111-30.
79. Zhang H, Cifone MA, Murli H, Erexson GL, Mecchi MS, Lawlor TE. Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food Chem Toxicol 2004;42:2021-8.
80. Jimenez-Ferrer JE, Perez-Teran YY, Roman-Ramos R, Tortoriello J. Antitoxin activity of plants used in Mexican traditional medicine against scorpion poisoning. Phytomedicine 2005;12:116-22.
81. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-77.
82. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92.
83. Cheung TP, Xue C, Leung K, Chan K, Li CG. Aristolochic acids detected in some raw Chinesemedicinal herbs and manufactured herbal products - a consequence of inappropriate nomenclature and imprecise labelling? Clin Toxicol 2006;44:371-8.
84. Final report on carcinogens background document for aristolochic acids. Rep Carcinog Backgr Doc 2008:i-xxv, 1-246.
85. Lai MN, Wang SM, Chen PC, Chen YY, Wang JD. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2010;102:179-86.
86. Blumberg PM. Protein kinaseCas the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res 1988;48:1-8.
87. Han ZT, Zhu XX, Yang RY, Sun JZ, Tian GF, Liu XJ, et al. Effect of intravenous infusions of 12-O-tetradecanoylphorbol-13-acetate (TPA) in patients with myelocytic leukemia: preliminary studies on therapeutic efficacy and toxicity. Proc Natl Acad Sci U S A 1998;95:5357-61.
88. Lee HW, Ahn DH, Crawley SC, Li JD, Gum JR Jr, Basbaum CB, et al. Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B. J Biol Chem 2002;277:32624-31.
89. Han ZT, Tong YK, He LM, Zhang Y, Sun JZ, Wang TY, et al.12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced increase in depressed white blood cell counts in patients treated with cytotoxic cancer chemotherapeutic drugs. Proc Natl Acad Sci U S A 1998;95:5362-5.
90. 1/S phase: evidence for an effectmediated by PKCdelta. Mol Cell Endocrinol 2008;292:26-35.
91. Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, et al. Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice. Clin Cancer Res 2006;12:3444-51.
92. Furstenberger G, Berry DL, Sorg B, Marks F. Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A 1981;78:7722-6.
93. Smith LW, Culvenor CC. Plant sources of hepatotoxic pyrrolizidine alkaloids. J Nat Prod 1981;44:129-52.
94. Radominska-Pandya A. Preface. Drug Metab Rev 2010;42:1-2.
95. Edgar JA, Roeder E, Molyneux RJ. Honey from plants containing pyrrolizidine alkaloids: a potential threat to health. J Agric Food Chem 2002;50:2719-30.
96. Kempf M, Reinhard A, Beuerle T. Pyrrolizidine alkaloids (PAs) in honey and pollen-legal regulation of PA levels in food and animal feed required. Mol Nutr Food Res 2010;54:158-68.
97. Ceuppens S, Rajkovic A, Heyndrickx M, Tsilia V, Van De Wiele T, Boon N, et al. Regulation of toxin production by Bacillus cereus and its food safety implications. Crit Rev Microbiol 2011;37:188-213.
98. Martin A, Beutin L. Characteristics of Shiga toxin-producing Escherichia coli frommeat andmilk products of different origins and association with food producing animals as main contamination sources. Int J Food Microbiol 2011;146:99-104.
99. Edgar JA, Colegate SM, BoppreM, Molyneux RJ. Pyrrolizidine alkaloids in food: a spectrum of potential health consequences. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2011;28:308-24.
100. Biesta-Peters EG, Reij MW, Blaauw RH, In't Veld PH, Rajkovic A, Ehling-Schulz M, et al. Quantification of the emetic toxin cereulide in food products by liquid chromatography-mass spectrometry using synthetic cereulide as a standard. Appl Environ Microbiol 2010;76:7466-72.
101. Coulombe RA Jr. Pyrrolizidine alkaloids in foods. Adv Food Nutr Res 2003;45:61-99.
102. Schoental R. Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res 1968;28:2237-46.
103. Zhao Y, Xia Q, Yin JJ, Lin G, Fu PP. Photoirradiation of dehydropyrrolizidine alkaloids-formation of reactive oxygen species and induction of lipid peroxidation. Toxicol Lett 2011;205:302-9.
104. Betz JM, Eppley RM, Taylor WC, Andrzejewski D. Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). J Pharm Sci 1994;83:649-53.
105. Mei N, Guo L, Fu PP, Fuscoe JC, Luan Y, Chen T. Metabolism, genotoxicity, and carcinogenicity of comfrey. J Toxicol Environ Health B Crit Rev 2010;13:509-26.
106. Mei N, Guo L, Zhang L, Shi L, Sun YA, Fung C, et al. Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale). BMC Bioinformatics 2006;7:S16.
107. Mei N, Guo L, Liu R, Fuscoe JC, Chen T. Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats. BMC Bioinformatics 2007;8:S4.
108. Mei N, Chou MW, Fu PP, Heflich RH, Chen T. Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats. Cancer Lett 2004;215:151-8.
109. Guo L, Mei N, Dial S, Fuscoe J, Chen T. Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinformatics 2007;8:S22.
110. Fu PP, Yang YC, Xia Q, Chou MC, Cui YY, Lin G. Pyrrolizidine alkaloids - tumorigenic components in Chinese herbal medicines and dietary supplements. J Food Drug Anal 2002;10:198-211.
111. Roder E. Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie 1995;50:83-98.
112. Weisbord SD, Soule JB, Kimmel PL. Poison on line - acute renal failure caused by oil of wormwood purchased through the Internet. N Engl J Med 1997;337:825-7.
113. Winickoff JP, Houck CS, Rothman EL, Bauchner H. Verve and Jolt: deadly new Internet drugs. Pediatrics 2000;106:829-30.
114. Gold LS, Slone TH. Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. N Engl J Med 2003;349:1576-7.
115. Bessell TL, Anderson JN, Silagy CA, Sansom LN, Hiller JE. Surfing, self-medicating and safety: buying non-prescription and complementary medicines via the internet. Qual Saf Health Care 2003;12:88-92.
116. Bonakdar RA. Herbal cancer cures on the Web: noncompliance with the dietary supplement health and education act. Fam Med 2002;34:522-7.
117. Morris CA, Avorn J. Internet marketing of herbal products. JAMA 2003;290:1505-9.